Thus, we conclude that at least in the cells tested here: myeloma cell lines, human mesenchymal stem cells, the monocytic THP-1 cell line and monocyte-derived human macrophages, we found no evidence that pure GDF15 was able to activate SMAD2. This evidence concerns the gene SMAD2 and plasma cell myeloma.